ClearStar – a leading workforce drug and alcohol testing provider – will be an exhibitor at the 2023 National Drug and Alcohol Screening Association (NDASA) Annual Conference & Trade Show from May 23, 2023, to May 25, 2023, at the Hyatt Regency Bellevue in Bellevue, Washington. ClearStar will be exhibiting at Booth 114 in the Hyatt Regency Grand Ballroom.
ClearStar will be represented at the 2023 NDASA Conference & Trade Show by Todd Shoulberg, President of Medical Information Services at ClearStar, who provides direction and leadership to the daily operations of ClearStar’s Medical Review Office (MRO). He will be joined in Booth 114 by Allison Crump, MRO Manager of Medical Information Services at ClearStar.
“NDASA’s Conference and Trade Show is the largest, most exciting, and relevant event of the year for the drug and alcohol testing industry. These three days of learning and sharing are designed to cultivate and advance knowledge and expertise in the fields of drug and alcohol testing, workplace safety, and public safety,” states the 2023 NDASA Conference web page.
“Invaluable professional training sessions, nationally-respected speakers and leaders, great networking opportunities – all with the common mission of supporting excellence in the drug and alcohol testing industry and promoting safe and drug-free workplaces. This is what NDASA’s Annual Conference is all about,” the 2023 NDASA Conference web page explains.
The mission of the National Drug and Alcohol Screening Association (NDASA) is to advocate for safe and drug-free workplaces and communities through legislative advocacy, education, training, and excellence in drug and alcohol screening services. To learn more, visit their website at NDASA.com. Additional information about the 2023 NDASA Conference is available here.
ClearStar is a leading Human Resources technology company specializing in background checks, drug testing, and occupational health screening. ClearStar offers drug and alcohol testing at more than 15,000 convenient drug test locations and 3,600 rated clinics in the United States. To learn more about ClearStar, visit us at Booth 114 or contact us today.
© 2023 ClearStar. All rights reserved. – Making copies of or using any part of the ClearStar website for any purpose is prohibited unless written authorization is first obtained from ClearStar. ClearStar does not provide or offer legal services or legal advice of any kind or nature. Any information on this website is for educational purposes only.
Let's start a conversation
Thomas Ahearn - Digital Content Editor
Thomas Ahearn is a Digital Content Editor at ClearStar, a leading Human Resources (HR) technology company specializing in background checks, drug testing, and occupational health screening. He writes about a variety of topics in the background screening industry including Artificial Intelligence (AI), "Ban the Box," class action lawsuits, credit reports, criminal records, drug testing, Equal Employment Opportunity Commission (EEOC), Fair Credit Reporting Act (FCRA), Form I-9, identity theft, privacy, social media screening, and workplace violence.
At ClearStar, we are committed to your success. An important part of your employment screening program involves compliance with various laws and regulations, which is why we are providing information regarding screening requirements in certain countries, region, etc. While we are happy to provide you with this information, it is your responsibility to comply with applicable laws and to understand how such information pertains to your employment screening program. The foregoing information is not offered as legal advice but is instead offered for informational purposes. ClearStar is not a law firm and does not offer legal advice and this communication does not form an attorney client relationship. The foregoing information is therefore not intended as a substitute for the legal advice of a lawyer knowledgeable of the user’s individual circumstances or to provide legal advice. ClearStar makes no assurances regarding the accuracy, completeness, or utility of the information contained in this publication. Legislative, regulatory and case law developments regularly impact on general research and this area is evolving rapidly. ClearStar expressly disclaim any warranties or responsibility or damages associated with or arising out of the information provided herein.
